Bovine lactoferrin
This article was originally published in The Tan Sheet
Executive Summary
DMV International GRAS submission for milk-derived ingredient in sports and functional foods receives de facto affirmation from FDA. Initial notice, submitted by DMV in April 2000, was rejected by agency for lack of data, FDA letter notes. Agency shifts stance based on additional material submitted by DMV showing exposure to bovine lactoferrin does not increase individual's sensitivity to milk and lactoferrin's association with autoimmune disorders. Ingredient supplier continues to seek GRAS status for ingredient in infant formula
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning